VANI
Vivani Medical Inc.
NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY
$1.34
+1.52% today
Updated 2026-04-30
Market cap
$115.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
Vivani Medical Inc. (VANI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-159.60%
ROA
-42.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $1.37M | $-16.28M | -221.58% | -1,171.82% | -1,190.67% |
| 2013 | $1.56M | $-22.97M | -259.72% | -1,150.05% | -1,467.73% |
| 2014 | $3.40M | $-35.20M | -4.72% | -624.91% | -1,035.99% |
| 2015 | $8.95M | $-20.02M | 51.93% | -223.99% | -223.66% |
| 2016 | $3.98M | $-33.18M | -134.60% | -833.38% | -832.60% |
| 2017 | $7.96M | $-28.52M | 2.65% | -360.48% | -358.06% |
| 2018 | $6.90M | $-35.09M | 29.12% | -505.00% | -508.90% |
| 2019 | $3.38M | $-33.59M | 36.31% | -905.50% | -994.14% |
| 2020 | $1000.00 | $-9.28M | -16,700.00% | -924,300.00% | -927,900.00% |
| 2021 | $260.00 | $-12.77M | -132,692.31% | -5,124,230.77% | -4,912,692.31% |
| 2022 | $0.00 | $-13.89M | — | — | — |
| 2023 | $0.00 | $-25.65M | — | — | — |
| 2024 | $0.00 | $-23.49M | — | — | — |
| 2025 | $0.00 | $-26.61M | — | — | — |